Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain.

BACKGROUND & AIMS Esophageal hypersensitivity is thought to be important in the generation and maintenance of symptoms in noncardiac chest pain (NCCP). In this study, we explored the neurophysiologic basis of esophageal hypersensitivity in a cohort of NCCP patients. METHODS We studied 12 healthy controls (9 women; mean age, 37.1 +/- 8.7 y) and 32 NCCP patients (23 women; mean age, 47.2 +/- 10 y). All had esophageal manometry, esophageal evoked potentials to electrical stimulation, and NCCP patients had 24-hour ambulatory pH testing. RESULTS The NCCP patients had reduced pain thresholds (PT) (72.1 +/- 19.4 vs 54.2 +/- 23.6, P = .02) and increased P1 latencies (P1 = 105.5 +/- 11.1 vs 118.1 +/- 23.4, P = .02). Subanalysis showed that the NCCP group could be divided into 3 distinct phenotypic classifications. Group 1 had reduced pain thresholds in conjunction with normal/reduced latency P1 latencies (n = 9). Group 2 had reduced pain thresholds in conjunction with increased (>2.5 SD) P1 latencies (n = 7), and group 3 had normal pain thresholds in conjunction with either normal (n = 10) or increased (>2.5 SD, n = 3) P1 latencies. CONCLUSIONS Normal esophageal evoked potential latencies with reduced PT, as seen in group 1 patients, is indicative of enhanced afferent transmission and therefore increased esophageal afferent pathway sensitivity. Increased esophageal evoked potential latencies with reduced PT in group 2 patients implies normal afferent transmission to the cortex but heightened secondary cortical processing of this information, most likely owing to psychologic factors such as hypervigilance. This study shows that NCCP patients with esophageal hypersensitivity may be subclassified into distinct phenotypic subclasses based on sensory responsiveness and objective neurophysiologic profiles.

[1]  A. Hobson,et al.  The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. , 2004, Gastroenterology.

[2]  W. Whitehead,et al.  Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. , 1998, Gastroenterology.

[3]  P. Furlong,et al.  Development of Esophageal Hypersensitivity Following Experimental Duodenal Acidification , 2004, American Journal of Gastroenterology.

[4]  S. Hollerbach,et al.  Estimation of habituation and signal-to-noise ratio of cortical evoked potentials to oesophageal electrical and mechanical stimulation , 1997, Medical and Biological Engineering and Computing.

[5]  J. Richter.  Oesophageal motility disorders , 2001, The Lancet.

[6]  C. Dalton,et al.  Cerebral potentials evoked by oesophageal distension in patients with non-cardiac chest pain. , 1992, Gut.

[7]  A. Halliday,et al.  Evoked potentials in clinical testing , 1982 .

[8]  E. Quigley.  New developments in the pathophysiology of gastro‐oesophageal reflux disease (GERD): implications for patient management , 2003, Alimentary pharmacology & therapeutics.

[9]  P. Furlong,et al.  A cortical evoked potential study of afferents mediating human esophageal sensation. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[10]  G. Barnes,et al.  Real-time imaging of human cortical activity evoked by painful esophageal stimulation. , 2005, Gastroenterology.

[11]  S. Hollerbach,et al.  The magnitude of the central response to esophageal electrical stimulation is intensity dependent. , 1997, Gastroenterology.

[12]  E. Fallen,et al.  Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP) , 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  S. Achem.  Treatment of spastic esophageal motility disorders. , 2004, Gastroenterology clinics of North America.

[14]  G. Eslick.  Noncardiac chest pain: epidemiology, natural history, health care seeking, and quality of life. , 2004, Gastroenterology clinics of North America.

[15]  A. Hobson,et al.  The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. , 2003, Gastroenterology.

[16]  M. Mandelkern,et al.  Brain Responses to Visceral and Somatic Stimuli in Patients With Irritable Bowel Syndrome With and Without Fibromyalgia , 2003, American Journal of Gastroenterology.

[17]  A. Lembo.  Visceral hypersensitivity in noncardiac chest pain. , 2004, Gastroenterology clinics of North America.

[18]  J. Vieth,et al.  The electrical and magnetical cerebral responses evoked by electrical stimulation of the esophagus and the location of their cerebral sources , 1999, Clinical Neurophysiology.

[19]  D. Castell,et al.  Esophageal balloon distention and cerebral evoked potential recording in the evaluation of unexplained chest pain. , 1992, The American journal of medicine.

[20]  Sarkar,et al.  Identification of the optimal parameters for recording cortical potentials evoked by mechanical stimulation of the human oesophagus , 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  L. Chang,et al.  Review article: epidemiology and quality of life in functional gastrointestinal disorders , 2004, Alimentary pharmacology & therapeutics.

[22]  V. Andrew Stenger,et al.  Cerebral activation during hypnotically induced and imagined pain , 2004, NeuroImage.

[23]  Aziz,et al.  Identification of the optimal parameters for recording cortical evoked potentials to human oesophageal electrical stimulation , 1998, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[24]  E. Bullmore,et al.  The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. , 2003, Brain : a journal of neurology.

[25]  L. Garcia-Larrea,et al.  Contribution of attentional and cognitive factors to laser evoked brain potentials , 2003, Neurophysiologie Clinique/Clinical Neurophysiology.

[26]  T R DeMeester,et al.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring. , 1980, The Journal of thoracic and cardiovascular surgery.

[27]  B. Vogt,et al.  Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. , 2003, Gastroenterology.

[28]  R H Hunt,et al.  Cerebral-evoked potential responses following direct vagal and esophageal electrical stimulation in humans. , 1993, The American journal of physiology.

[29]  J. Richter.  Overview of diagnostic testing for chest pain of unknown origin. , 1992, The American journal of medicine.

[30]  R. Mittal,et al.  Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[31]  L. Arendt-Nielsen,et al.  Oesophageal sensation assessed by electrical stimuli and brain evoked potentials--a new model for visceral nociception. , 1995, Gut.

[32]  Shine,et al.  Cognitive evoked potentials to anticipated oesophageal stimulus in humans: quantitative assessment of the cognitive aspects of visceral perception , 1999, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[33]  J. Hutton.  Cognitive behaviour therapy for irritable bowel syndrome , 2005, European journal of gastroenterology & hepatology.

[34]  H. Jasper.  Report of the committee on methods of clinical examination in electroencephalography , 1958 .

[35]  A. Hobson,et al.  Contribution of central sensitisation to the development of noncardiac chest pain , 2000, The Lancet.

[36]  R. Fass.  Distinct Phenotypic Presentations of Gastroesophageal Reflux Disease: A New View of the Natural History , 2004, Digestive Diseases.

[37]  S. Derbyshire,et al.  Cerebral Activation in Patients With Irritable Bowel Syndrome and Control Subjects During Rectosigmoid Stimulation , 2001, Psychosomatic medicine.

[38]  J. Brooks,et al.  A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging , 2005, Pain.

[39]  P. Furlong,et al.  Cortical processing of human gut sensation: an evoked potential study. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[40]  M. Camilleri.  Drugs targeting functional bowel disorders: lessons from drug trials. , 2002, Current opinion in pharmacology.

[41]  R. Mittal.  Motor and sensory function of the esophagus: revelations through ultrasound imaging. , 2005, Journal of clinical gastroenterology.

[42]  R. Hunt,et al.  Cortical Evoked Responses Following Esophageal Balloon Distension and Electrical Stimulation in Healthy Volunteers , 1998, Digestive Diseases and Sciences.

[43]  Q Aziz,et al.  Central neural mechanisms mediating human visceral hypersensitivity. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[44]  Leah Fitzgerald,et al.  Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. , 2002, Gastroenterology.

[45]  Hiroshi Shibasaki,et al.  Somatosensory evoked potentials Diagnostic criteria and abnormalities in cerebral lesions , 1977, Journal of the Neurological Sciences.

[46]  Qasim Aziz,et al.  Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. , 2005, Gastroenterology.

[47]  R. Fass,et al.  Gastroesophageal reflux disease in noncardiac chest pain. , 2004, Gastroenterology clinics of North America.

[48]  A. Hobson,et al.  Brain imaging and functional gastrointestinal disorders: has it helped our understanding? , 2004, Gut.

[49]  H Franssen,et al.  Source modeling of esophageal evoked potentials. , 1996, Electroencephalography and clinical neurophysiology.

[50]  D. Hammond,et al.  Neurofeedback with anxiety and affective disorders. , 2005, Child and adolescent psychiatric clinics of North America.

[51]  R. Fass,et al.  The effect of an empirical trial of high‐dose lansoprazole on symptom response of patients with non‐cardiac chest pain – a randomized, double‐blind, placebo‐controlled, crossover trial , 2004, Alimentary pharmacology & therapeutics.

[52]  M. Valdovinos,et al.  Current and future treatment of chest pain of presumed esophageal origin. , 2004, Gastroenterology clinics of North America.